Literature DB >> 11709084

The sphingosine-1-phosphate receptor EDG-1 is essential for platelet-derived growth factor-induced cell motility.

H M Rosenfeldt1, J P Hobson, S Milstien, S Spiegel.   

Abstract

EDG-1, encoded by the endothelial differentiation gene-1, is a heterotrimeric guanine nucleotide binding protein-coupled receptor (GPCR) for sphingosine-1-phosphate (SPP) that has been shown to stimulate angiogenesis and cell migration in cultured endothelial cells. Unexpectedly, EDG-1 knockout embryos had a normal blood vessel network, vasculogenesis and angiogenesis, but died in utero owing to massive haemorrhaging as a result of failure of smooth muscle cells and pericytes to migrate around the circumference and reinforce endothelial tubes [Liu, Wada, Yamashita, Mi, Deng, Hobson, Rosenfeldt, Nava, Chae, Lee, et al. (2000) J. Clin. Invest. 106, 951-961]. This vascular maturation defect is similar to the phenotype of mice homozygous for disrupted alleles of platelet-derived growth factor B-subunit homodimer (PDGF-BB) or its receptor PDGFR-beta. We found that fibroblasts from EDG-1 null embryos did not migrate toward PDGF or SPP, and inhibition of motility correlated with defective activation of the small guanosine triphosphatase Rac, which is required for lamellipodia formation and directional locomotion [Hobson, Rosenfeldt, Barak, Olivera, Poulton, Caron, Milstien, and Spiegel (2001) Science 291, 1800-1803]. Moreover, we showed that PDGF-directed cell migration requires both sphingosine kinase activation and expression of EDG-1, suggesting a functional link between PDGF signalling and EDG-1. Indeed, treatment of wild-type cells with PDGF transactivated EDG-1 as determined by translocation of beta-arrestin and phosphorylation of EDG-1. These findings reveal a new paradigm for receptor cross-communication in which activation of a GPCR by a receptor tyrosine kinase is critical for cell motility. Our observations might also clarify the role of EDG-1 in vascular maturation and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709084     DOI: 10.1042/0300-5127:0290836

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  10 in total

1.  Sphingosine kinase-dependent migration of immature dendritic cells in response to neurotoxic prion protein fragment.

Authors:  Nicole C Kaneider; Arthur Kaser; Stefan Dunzendorfer; Herbert Tilg; Christian J Wiedermann
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  Vascular smooth muscle cell motility is mediated by a physical and functional interaction of Ca2+/calmodulin-dependent protein kinase IIδ2 and Fyn.

Authors:  Roman Ginnan; Xiaojing Zou; Paul J Pfleiderer; Melissa Z Mercure; Margarida Barroso; Harold A Singer
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

3.  Roles of sphingosine 1-phosphate on tumorigenesis.

Authors:  Yuan-Li Huang; Wei-Pang Huang; Hsinyu Lee
Journal:  World J Biol Chem       Date:  2011-02-26

4.  Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.

Authors:  Lauren Bryan; Barbara S Paugh; Dmitri Kapitonov; Katarzyna M Wilczynska; Silvina M Alvarez; Sandeep K Singh; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

5.  Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity.

Authors:  Janet L Martin; Mike Z Lin; Eileen M McGowan; Robert C Baxter
Journal:  J Biol Chem       Date:  2009-07-25       Impact factor: 5.157

6.  Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants.

Authors:  Reza Soleimani; Elke Heytens; Kutluk Oktay
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

7.  Sphingosine-1-Phosphate and the S1P3 Receptor Initiate Neuronal Retraction via RhoA/ROCK Associated with CRMP2 Phosphorylation.

Authors:  Serena Quarta; Maria Camprubí-Robles; Rüdiger Schweigreiter; Dusan Matusica; Rainer V Haberberger; Richard L Proia; Christine E Bandtlow; Antonio Ferrer-Montiel; Michaela Kress
Journal:  Front Mol Neurosci       Date:  2017-10-10       Impact factor: 5.639

Review 8.  Vasculogenic cytokines in wound healing.

Authors:  Victor W Wong; Jeffrey D Crawford
Journal:  Biomed Res Int       Date:  2013-02-28       Impact factor: 3.411

Review 9.  Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy.

Authors:  Bárbara González-Fernández; Diana I Sánchez; Javier González-Gallego; María J Tuñón
Journal:  Front Pharmacol       Date:  2017-08-25       Impact factor: 5.810

10.  Loss of Regulator of G-Protein Signaling 5 Leads to Neurovascular Protection in Stroke.

Authors:  Ilknur Özen; Michaela Roth; Marco Barbariga; Abderahim Gaceb; Tomas Deierborg; Guillem Genové; Gesine Paul
Journal:  Stroke       Date:  2018-09       Impact factor: 7.914

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.